Search hospitals > Virginia > Norfolk
Sentara Norfolk General Hospital
Claim this profileNorfolk, Virginia 23507
Global Leader in Heart Failure
Global Leader in Atrial Fibrillation
Conducts research for Aortic Valve Stenosis
Conducts research for Coronary Artery Disease
Conducts research for Aortic Stenosis
215 reported clinical trials
25 medical researchers
Summary
Sentara Norfolk General Hospital is a medical facility located in Norfolk, Virginia. This center is recognized for care of Heart Failure, Atrial Fibrillation, Aortic Valve Stenosis, Coronary Artery Disease, Aortic Stenosis and other specialties. Sentara Norfolk General Hospital is involved with conducting 215 clinical trials across 252 conditions. There are 25 research doctors associated with this hospital, such as Paul Mahoney, MD, David Dexter, MD, Jean Panneton, MD, and Joseph Newton, MD.Top PIs
Paul Mahoney, MDSentara Norfolk General Hospital6 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Mitral Valve Regurgitation
18 reported clinical trials
29 drugs studied
David Dexter, MDSentara Vascular Specialists3 years of reported clinical research
Studies Deep Vein Thrombosis
Studies Blood Clot
13 reported clinical trials
12 drugs studied
Jean Panneton, MDSentara Heart Hospital3 years of reported clinical research
Studies Aortic Aneurysm
Studies Abdominal Aortic Aneurysm
9 reported clinical trials
9 drugs studied
Joseph Newton, MDSentara Norfolk General Hospital5 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Aortic Stenosis
6 reported clinical trials
11 drugs studied
Clinical Trials running at Sentara Norfolk General Hospital
Non-Small Cell Lung Cancer
Deep Vein Thrombosis
Heart Failure
Lung Cancer
Mitral Valve Regurgitation
Blood Clot
Atrial Fibrillation
Squamous Cell Carcinoma
Pancreatic Cancer
Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Sentara Norfolk General Hospital?
Sentara Norfolk General Hospital is a medical facility located in Norfolk, Virginia. This center is recognized for care of Heart Failure, Atrial Fibrillation, Aortic Valve Stenosis, Coronary Artery Disease, Aortic Stenosis and other specialties. Sentara Norfolk General Hospital is involved with conducting 215 clinical trials across 252 conditions. There are 25 research doctors associated with this hospital, such as Paul Mahoney, MD, David Dexter, MD, Jean Panneton, MD, and Joseph Newton, MD.